Carasent releases Q3 interim report highlighting strong financial growth
Contracted ARR reached SEK 424m with 29% YoY growth. EBITDAC margin improved to 20%. The company also launched its AI assistant Medsum and appointed a new CEO in Germany.
See the latest news and media coverage for Carasent. We track all announcements, press releases, and industry mentions in real time, all in one place.
Health tech group providing digital healthcare solutions
carasent.comLast updated
In short: Carasent reported strong Q3 2026 results, with net sales up 32% and contracted ARR up 29%.
Contracted ARR reached SEK 424m with 29% YoY growth. EBITDAC margin improved to 20%. The company also launched its AI assistant Medsum and appointed a new CEO in Germany.
The company achieved SEK 108.2 million in net sales and acquired Infosolutions, while AI features expand.
The company acquired InfoSolutions, achieved 15% organic ARR growth, and posted a 19% adjusted EBITDA margin.
The interim report publishes July 10 at 07:00, followed by a webcast at 08:00 CET. Registration links provided.
Carasent AB has released the results for the third quarter and the first nine months ended September 30, 2026. In the third quarter, the company achieved...
Carasent AB (CARA.ST) announced earnings for third quarter that Dropped, from the same period last year The company's earnings totaled SEK10.30 million, or SEK0.15 per...
What is the stock ticker for Carasent AB? The stock ticker for Carasent AB is "CARAS". On which stock exchange is Carasent AB traded? Carasent AB is listed on...
Carasent said second-quarter revenue rose 18% from a year earlier to SEK 97.7 million, while adjusted EBITDA margin improved to 11% from 3% a year...
Track Carasent and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Carasent and other trending companies.